![](/img/cover-not-exists.png)
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Fassnacht, Martin, Berruti, Alfredo, Baudin, Eric, Demeure, Michael J, Gilbert, Jill, Haak, Harm, Kroiss, Matthias, Quinn, David I, Hesseltine, Elizabeth, Ronchi, Cristina L, Terzolo, Massimo, ChoueirVolume:
16
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(15)70081-1
Date:
April, 2015
File:
PDF, 539 KB
english, 2015